The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Will Be The Estimated Market Size Of The Automation In Biopharma Industry Market By 2030?

Strong growth has been observed in the automation in biopharma industry market size in recent years. This market is projected to increase from $2.19 billion in 2025 to $2.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. Key factors contributing to this historical expansion include the escalating complexity of biologic drug production, rising demand for scalable biopharma manufacturing, early adoption of laboratory automation, the expansion of contract manufacturing services, and advancements in process control technologies.

The automation in biopharma industry market size is projected to undergo robust expansion over the next few years. It is forecast to reach $3.16 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. The growth anticipated during this forecast period can be attributed to several factors, including increasing investments in smart biomanufacturing facilities, the growing adoption of continuous manufacturing processes, the expansion of personalized biologics production, a rising demand for regulatory-compliant automation, and an increasing focus on optimizing manufacturing efficiency. Key trends for the forecast period encompass the increasing adoption of robotic manufacturing platforms, the rising integration of digital twin technologies, the growing use of automated quality control systems, the expansion of end-to-end bioprocess automation, and an enhanced focus on data-driven manufacturing.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

What Influential Factors Are Boosting The Automation In Biopharma Industry Market Demand?

The expanding integration of robots within pharmaceutical production is projected to boost the expansion of the automation in biopharma industry market. These robots, utilized in pharmaceutical manufacturing, are sophisticated automated systems and machinery designed to execute diverse functions in the fabrication and packaging of pharmaceutical goods. Their widespread application in pharmaceutical production encompasses areas like secondary packaging, intralogistics, laboratory automation, pick and place operations, the automation of pharmacy processes, and personalized medicine, leading to benefits such as increased productivity, improved precision, a lower risk of contamination, and enhanced safety for workers. As an illustration, in September 2024, the International Federation of Robotics, a professional non-profit organization based in Germany, reported that industrial robot installations across the manufacturing sector in Europe rose by 9%, reaching an unprecedented total of 92,393 units. Among these, 80% were deployed within the European Union, amounting to 73,534 units, which signifies a 2% increase compared to the prior year. Consequently, the growing integration of robots in pharmaceutical production will propel the expansion of the automation in biopharma industry market.

Which Segment-Based Categories Are Covered In The Automation In Biopharma Industry Market?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

Which Trends Are Supporting The Evolution Of The Automation In Biopharma Industry Market?

Significant companies are driving automation in the biopharma industry market, concentrating on creating technological advancements such as robotic platforms for cell-therapy manufacturing, designed to enable scalable, efficient, and less error-prone production of advanced therapies. Such a robotic cell-therapy manufacturing platform integrates mobile robotics, aseptic fluid-handling systems, automated tube welding, and digital process control within a completely closed and modular system. This innovation supersedes conventional manual bioprocessing, which heavily depends on labor and open setups. For example, in May 2023, Cellular Origins, a UK-based life sciences automation company, introduced Constellation, a configurable robotic platform tailored for advanced therapy manufacture. This particular platform incorporates autonomous mobile robots, sterile fluid-transfer technology, and modular processing consoles, facilitating smooth integration into existing bioprocessing workflows. It significantly enhances space efficiency by 30 times, decreases labor requirements by 16-fold, and lowers production costs by 51%, concurrently providing comprehensive digital interconnection for quality control and remote monitoring.

Who Are The Firms Contributing To The Automation In Biopharma Industry Market Ecosystem?

Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Access The Complete Automation In Biopharma Industry Market Report:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Which Region Holds The Largest Share In The Automation In Biopharma Industry Market?

North America was the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Automation In Biopharma Industry Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp

Browse Through More Reports Similar to the Global Automation In Biopharma Industry Market 2026, By The Business Research Company

Bioprocess Automation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioprocess-automation-global-market-report

Pharmacy Automation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-global-market-report

Pharmacy Automation Systems Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model